Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gennarelli

Showing results (121-130 of 213) with videos related to

Pageof 22
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2006
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patientsLuisella Bocchio-Chiavetto, Roberta Zanardini, Marco Bortolomasi, et al.
BMC Neuroscience|February 10, 2010
BDNF Val66Met polymorphism and protein levels in amniotic fluidAnnamaria Cattaneo, Luisella Bocchio-Chiavetto, Roberta Zanardini, et al.
Current Neuropharmacology|June 2, 2026
Exploring the Influence of Inflammation on the Pharmacokinetics of Antidepressants and Antipsychotics: A Systematic ReviewGiuseppe Cicala, Maria Antonietta Barbieri, Alessandro Gialluisi, et al.
The Journal of ECT|January 10, 2025
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed PatientsChiara Galbiati, Vincenzo Dattilo, Marco Bortolomasi, et al.
Frontiers in Psychiatry|November 29, 2023
The role of pharmacogenetics in the treatment of major depressive disorder: a critical reviewStefano Barlati, Alessandra Minelli, Gabriele Nibbio, et al.
Psychiatric Genetics|December 14, 2007
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control studyRossella Gulli, Bianca Masnata, Cristian Bonvicini, et al.
Genetic Testing|March 31, 2007
Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patientsLeila Baghernajad Salehi, Emanuela Bonifazi, Enrico Di Stasio, et al.
Journal of Personalized Medicine|November 27, 2021
Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive TherapyClaudia Pisanu, Erika Vitali, Anna Meloni, et al.
BMC Psychiatry|September 20, 2012
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorderElena Milanesi, Alessandra Minelli, Nadia Cattane, et al.
Journal of Molecular Neuroscience : MN|March 6, 2015
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder PatientsElena Milanesi, Adva Hadar, Elisabetta Maffioletti, et al.
Pageof 22

Showing results (121-130 of 213) with videos related to

Sort By:
Pageof 22
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2006
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patientsLuisella Bocchio-Chiavetto, Roberta Zanardini, Marco Bortolomasi, et al.
BMC Neuroscience|February 10, 2010
BDNF Val66Met polymorphism and protein levels in amniotic fluidAnnamaria Cattaneo, Luisella Bocchio-Chiavetto, Roberta Zanardini, et al.
Current Neuropharmacology|June 2, 2026
Exploring the Influence of Inflammation on the Pharmacokinetics of Antidepressants and Antipsychotics: A Systematic ReviewGiuseppe Cicala, Maria Antonietta Barbieri, Alessandro Gialluisi, et al.
The Journal of ECT|January 10, 2025
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed PatientsChiara Galbiati, Vincenzo Dattilo, Marco Bortolomasi, et al.
Frontiers in Psychiatry|November 29, 2023
The role of pharmacogenetics in the treatment of major depressive disorder: a critical reviewStefano Barlati, Alessandra Minelli, Gabriele Nibbio, et al.
Psychiatric Genetics|December 14, 2007
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control studyRossella Gulli, Bianca Masnata, Cristian Bonvicini, et al.
Genetic Testing|March 31, 2007
Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patientsLeila Baghernajad Salehi, Emanuela Bonifazi, Enrico Di Stasio, et al.
Journal of Personalized Medicine|November 27, 2021
Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive TherapyClaudia Pisanu, Erika Vitali, Anna Meloni, et al.
BMC Psychiatry|September 20, 2012
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorderElena Milanesi, Alessandra Minelli, Nadia Cattane, et al.
Journal of Molecular Neuroscience : MN|March 6, 2015
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder PatientsElena Milanesi, Adva Hadar, Elisabetta Maffioletti, et al.
Pageof 22